CTRI/2011/11/002118已完成3 期
A Ph III, Single Arm, Multi-Center, Open-Label Study to Assess the Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent Vaccine Quinvaxem (DTwP-Hib-HepB Vaccine) when Administered to Indian Infants at 6, 10, and 14 Weeks of Age
ovartis Healthcare Pvt Ltd Vaccines Division0 个研究点目标入组 175 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 175
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy infants without any contradictions to receive investigational vaccine
排除标准
- •1.Parents unwilling or unable to provide written informed consent
- •2. History of previous immunization with a vaccine containing any of the 5 antigen components of investigational vaccine.
- •3.Known hypersensitivity or allergic reactions after previous vaccinations
- •4.Presence of any significant medical condition
研究者
相似试验
进行中（未招募）
不适用
Safety and Tolerability of a Fully Liquid Pentavalent Vaccine Quinvaxem® when Administered to Indian Infants at 6, 10, and 14 Weeks of AgeProphilaxis against diphtheria, tetanus, pertussis, hepatitis B and invasive Haemophilus influenzae type b disease.EUCTR2014-005309-18-Outside-EU/EEAovartis Vaccines and Diagnostics175
进行中（未招募）
1 期
A study evaluating venetoclax (ABT-199) in subjects with Chronic Lymphocytic Leukemia (CLL) whose cancer has come back or who had no response to previous cancer treatments.Chronic Lymphocytic LeukemiaEUCTR2016-001097-15-BGAbbVie Deutschland GmbH & Co. KG200
已完成
3 期
Open-Label, Single Arm, Phase 3b, Multi-Center Study Evaluating the Efficacy of Venetoclax (ABT-199) in Relapsed/Refractory Subjects with Chronic Lymphocytic Leukemia (CLL)Cancer of the blood10024324LeukemiaNL-OMON55465AbbVie B.V.8
进行中（未招募）
1 期
A study evaluating venetoclax (ABT-199) in subjects with Chronic Lymphocytic Leukemia (CLL) whose cancer has come back or who had no response to previous cancer treatments.MedDRA version: 20.0Level: PTClassification code 10008958Term: Chronic lymphocytic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Chronic Lymphocytic LeukemiaEUCTR2016-001097-15-HUAbbVie Deutschland GmbH & Co. KG200
进行中（未招募）
1 期
A study evaluating venetoclax (ABT-199) in subjects with Chronic Lymphocytic Leukemia (CLL) whose cancer has come back or who had no response to previous cancer treatments.MedDRA version: 20.0Level: PTClassification code 10008958Term: Chronic lymphocytic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Chronic Lymphocytic LeukemiaEUCTR2016-001097-15-PLAbbVie Deutschland GmbH & Co. KG200